Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation.

about

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation.

Item

http://www.wikidata.org/entity/Q52656964

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@en

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@nl

type

Item

label

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@en

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@nl

prefLabel

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@en

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@nl

P1476

Rituximab and Monitoring Strat ...... After Kidney Transplantation.

@en

P2093

Arjang Djamali

http://www.w3.org/2001/XMLSchema#string

Brad C Astor

http://www.w3.org/2001/XMLSchema#string

Brenda Muth

http://www.w3.org/2001/XMLSchema#string

Didier A Mandelbrot

http://www.w3.org/2001/XMLSchema#string

Fahad Aziz

http://www.w3.org/2001/XMLSchema#string

Maha Mohamed

http://www.w3.org/2001/XMLSchema#string

Neetika Garg

http://www.w3.org/2001/XMLSchema#string

Robert R Redfield

http://www.w3.org/2001/XMLSchema#string

Sandesh Parajuli

http://www.w3.org/2001/XMLSchema#string

Weixiong Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of antibody-mediated rejection: current status and novel approaches.

Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.

Advances in diagnosing and managing antibody-mediated rejection.

Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum.

Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.

Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies.

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

P304

e227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TXD.0000000000000746

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29536028

http://www.w3.org/2001/XMLSchema#string

P932

5828696

http://www.w3.org/2001/XMLSchema#string